Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--response. uri icon

Overview

publication date

  • January 9, 2014

Research

keywords

  • CTLA-4 Antigen
  • Cancer Vaccines
  • Neoplasms, Experimental
  • Programmed Cell Death 1 Receptor
  • T-Lymphocytes

Identity

Scopus Document Identifier

  • 84892924268

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-13-2752

PubMed ID

  • 24408920

Additional Document Info

volume

  • 74

issue

  • 2